80 related articles for article (PubMed ID: 2627124)
1. Repeated blast crisis (BC) of changing morphology, immunologic phenotype and cytogenetics in chronic myeloid leukemia (CML).
Jehn U; Mittermüller J; Greither L; Clemm C; Heinemann V; Lorenz T; Gross HJ
Anticancer Res; 1989; 9(6):1721-3. PubMed ID: 2627124
[TBL] [Abstract][Full Text] [Related]
2. Phenotype of blasts in chronic myeloid leukemia in blastic phase-Analysis of bone marrow trephine biopsies and correlation with cytogenetics.
Reid AG; De Melo VA; Elderfield K; Clark I; Marin D; Apperley J; Naresh KN
Leuk Res; 2009 Mar; 33(3):418-25. PubMed ID: 18760473
[TBL] [Abstract][Full Text] [Related]
3. Chronic myelogenous leukemia showing biphenotypic blast crisis followed by lineage switch to B lymphoblastic leukemia.
Oh SH; Park TS; Kim HR; Lee JY; Kim JH; Shin JH; Lee JN
Leuk Res; 2009 Nov; 33(11):e195-8. PubMed ID: 19446879
[TBL] [Abstract][Full Text] [Related]
4. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
Schmetzer HM; Gerhartz HH
Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
[TBL] [Abstract][Full Text] [Related]
5. The onset of CML in blastic crisis: molecular features.
Gregorini A; Filippetti A; Luchetti F; Walker A; Lillington DM; Papa S; Valentini M
J Biol Regul Homeost Agents; 1997; 11(3):111-4. PubMed ID: 9498160
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia.
López-Karpovitch X; Cárdenas R; Piedras J
Rev Invest Clin; 1997; 49(1):31-6. PubMed ID: 9229753
[TBL] [Abstract][Full Text] [Related]
7. [Chronic myelogenous leukemia characterized by successive lymphoid and myelomonocytic blast crises].
Shirai T; Hasegawa S; Niitani K; Nishimura T; Ishida H; Shinohara T
Rinsho Ketsueki; 1989 May; 30(5):668-73. PubMed ID: 2795881
[TBL] [Abstract][Full Text] [Related]
8. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A
Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376
[TBL] [Abstract][Full Text] [Related]
9. CD7+ TdT+ chronic myelogenous leukemia blast crisis with null genotype.
Smith MR; Mohamed AN; Karanes C
Leukemia; 1993 Feb; 7(2):177-80. PubMed ID: 7678877
[TBL] [Abstract][Full Text] [Related]
10. [Extramedullary blast crisis in chronic myeloid leukemia].
Cervantes F; Rozman M; Nicolás JM; López Guillermo A; Rozman C
Sangre (Barc); 1989 Apr; 34(2):96-8. PubMed ID: 2756456
[TBL] [Abstract][Full Text] [Related]
11. Extramedullary T cell lymphoblastic transformation of chronic myeloid leukaemia successfully treated with matched unrelated donor bone marrow transplantation.
Apfelbeck U; Hoefler G; Neumeister P; Fonatsch C; Linkesch W; Sill H
Bone Marrow Transplant; 2000 Nov; 26(10):1111-2. PubMed ID: 11108312
[TBL] [Abstract][Full Text] [Related]
12. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
[TBL] [Abstract][Full Text] [Related]
13. Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy.
Alimena G; Breccia M; Latagliata R; Carmosino I; Russo E; Biondo F; Diverio D; Mancini M; Nanni M; Mandelli F
Cancer; 2006 Sep; 107(5):1008-13. PubMed ID: 16878324
[TBL] [Abstract][Full Text] [Related]
14. Role of immunophenotyping in characterisation of blast crisis of chronic myeloid leukemia--a study of 25 cases.
Padmanabhan V; Varma N; Dash S; Varma S
Indian J Pathol Microbiol; 1996 Jan; 39(1):13-7. PubMed ID: 8755126
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between cellular and cytogenetic morphology using fluorescence in situ hybridization in the study of malignant hemopathies].
Martín-Henao GA; Aventín A; Espadaler M; Moltó E
Sangre (Barc); 1994 Jun; 39(3):203-6. PubMed ID: 7940051
[TBL] [Abstract][Full Text] [Related]
16. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
[TBL] [Abstract][Full Text] [Related]
18. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease.
Cuneo A; Balboni M; Piva N; Carli MG; Tomasi P; Previati R; Negrini M; Scapoli G; Spanedda R; Castoldi G
Haematologica; 1994; 79(1):76-82. PubMed ID: 15378954
[TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
[TBL] [Abstract][Full Text] [Related]
20. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
